FR22C1031I1 - PHARMACEUTICAL COMPOSITION COMPRISING DROSPIRENONE FOR USE AS A CONTRACEPTIVE - Google Patents

PHARMACEUTICAL COMPOSITION COMPRISING DROSPIRENONE FOR USE AS A CONTRACEPTIVE

Info

Publication number: FR22C1031I1
Authority: FR; France
Prior art keywords: drospirenone; contraceptive; pharmaceutical composition; pharmaceutical; composition
Prior art date: 2010-06-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

FR22C1031C

Other languages

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Laboratorios Leon Farma SA

Original Assignee

Laboratorios Leon Farma SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-06-29

Filing date

2022-06-23

Publication date

2022-09-09

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42671710&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR22C1031(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2022-06-23 Application filed by Laboratorios Leon Farma SA filed Critical Laboratorios Leon Farma SA

2022-09-09 Publication of FR22C1031I1 publication Critical patent/FR22C1031I1/en

2023-12-22 Application granted granted Critical

2023-12-22 Publication of FR22C1031I2 publication Critical patent/FR22C1031I2/en

Status Active legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Inorganic Chemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Gynecology & Obstetrics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

FR22C1031C 2010-06-29 2022-06-23 PHARMACEUTICAL COMPOSITION COMPRISING DROSPIRENONE FOR USE AS A CONTRACEPTIVE Active FR22C1031I2 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
EP10305708		2010-06-29
US36839610P	2010-07-28	2010-07-28
EP11727985.1A EP2588114B1 (en)	2010-06-29	2011-06-28	Pharmaceutical composition comprising drospirenone and contraceptive kit
PCT/EP2011/060795 WO2012000981A1 (en)	2010-06-29	2011-06-28	Pharmaceutical composition comprising drospirenone and contraceptive kit

Publications (2)

Publication Number	Publication Date
FR22C1031I1 true FR22C1031I1 (en)	2022-09-09
FR22C1031I2 FR22C1031I2 (en)	2023-12-22

Family

ID=42671710

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
FR20C1020C Active FR20C1020I1 (en)	2010-06-29	2020-06-11	PHARMACEUTICAL COMPOSITION CONTAINING DROSPIRENONE AND CONTRACEPTIVE KIT
FR22C1031C Active FR22C1031I2 (en)	2010-06-29	2022-06-23	PHARMACEUTICAL COMPOSITION COMPRISING DROSPIRENONE FOR USE AS A CONTRACEPTIVE

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
FR20C1020C Active FR20C1020I1 (en)	2010-06-29	2020-06-11	PHARMACEUTICAL COMPOSITION CONTAINING DROSPIRENONE AND CONTRACEPTIVE KIT

Country Status (25)

Country	Link
US (7)	US11452695B2 (en)
EP (3)	EP2588114B1 (en)
JP (1)	JP5810159B2 (en)
KR (3)	KR102164693B1 (en)
AR (1)	AR081670A1 (en)
BR (1)	BR112012033391B1 (en)
CA (3)	CA3003062C (en)
CY (2)	CY1122544T1 (en)
DK (1)	DK3632448T3 (en)
EA (1)	EA028680B1 (en)
ES (1)	ES2908657T3 (en)
FR (2)	FR20C1020I1 (en)
HR (1)	HRP20220332T1 (en)
HU (3)	HUE058176T2 (en)
LT (2)	LT3632448T (en)
NO (2)	NO2020015I1 (en)
NZ (1)	NZ605176A (en)
PE (2)	PE20130780A1 (en)
PH (1)	PH12012502499A1 (en)
PL (2)	PL3632448T3 (en)
PT (1)	PT3632448T (en)
RS (2)	RS59826B1 (en)
SI (2)	SI3632448T1 (en)
SM (2)	SMT202200129T1 (en)
WO (1)	WO2012000981A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US11351122B1 (en)	2010-07-28	2022-06-07	Laboratorios Leon Farma Sa	Synthetic progestogens and pharmaceutical compositions comprising the same
US10849857B2 (en)	2010-07-28	2020-12-01	Laboratorios Leon Farma Sa	Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
AR081670A1 (en)	2010-06-29	2012-10-10	Leon Farma Sa Lab	PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE AND ANTI-ECONCEPTIVE KIT
US9603860B2 (en)	2010-07-28	2017-03-28	Laboratorios Leon Farma Sa	Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
EP2383279A1 (en)	2011-07-19	2011-11-02	Pantarhei Bioscience B.V.	Process for the preparation of estetrol
US10888518B2 (en)	2015-06-18	2021-01-12	Estetra Sprl	Orodispersible tablet containing estetrol
SI3310333T1 (en)	2015-06-18	2020-08-31	Estetra Sprl	Orodispersible dosage unit containing an estetrol component
PE20180398A1 (en)	2015-06-18	2018-02-28	Mithra Pharmaceuticals S A	ORODISPERSABLE DOSING UNIT CONTAINING A STETROL COMPONENT
JP6866561B2 (en)	2015-06-18	2021-04-28	エステトラソシエテプリーヴアレスポンサビリテリミテ	Orally disintegrating tablets containing estetrol
EP3313408B1 (en) *	2015-06-23	2023-12-06	Laboratorios Leon Farma SA	Drospirenone-based contraceptive for a female patient affected with excess weight
EP3108889A1 (en)	2015-06-23	2016-12-28	Philippe Perrin	Drospirenone-based contraceptive for a female patient affected with excess weight
CA3178291A1 (en)	2016-08-05	2018-04-12	Estetra Srl	Method for the management of dysmenorrhea and menstrual pain
TWI801561B (en)	2018-04-19	2023-05-11	比利時商依思特拉私人有限責任公司	Compounds and their uses for alleviating menopause-associated symptoms
JOP20200260A1 (en)	2018-04-19	2019-10-19	Estetra Sprl	Compounds and their uses for alleviating menopause-associated symptoms
EP4134082A1 (en)	2021-08-12	2023-02-15	Chemo Research, S.L.	Method for treating endometriosis and providing effective contraception
WO2023152658A1 (en)	2022-02-10	2023-08-17	Lupin Limited	Slow release drospirenone tablet composition
EP4486311A1 (en)	2022-03-01	2025-01-08	Chemo Research, S.L.	Chewable oral contraceptive

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2652761C2 (en)	1976-11-16	1985-11-21	Schering AG, 1000 Berlin und 4709 Bergkamen	15,16-methylene-spirolactones, processes for their preparation and pharmaceuticals containing them
DE3022337A1 (en)	1980-06-11	1982-01-07	Schering Ag Berlin Und Bergkamen, 1000 Berlin	Compsns. for contraception or treatment of gynaecological disorders - contg. 6 beta, 7 beta; 15 delta, 16 beta-di:methylene-3-oxo-4-androstene-17(beta-1')-spiro-5'-per:hyd- ro-furan-2'-one
DE69112917T2 (en)	1990-06-15	1996-05-15	Merck & Co Inc	Crystallization process to improve the crystal structure and size.
GB2256648B (en)	1991-05-29	1995-08-30	Colorcon Ltd	Wax polish composition
DE19633685C1 (en)	1996-08-12	1997-10-09	Schering Ag	Production of drospirenone useful as steroidal agent
US6787531B1 (en)	1999-08-31	2004-09-07	Schering Ag	Pharmaceutical composition for use as a contraceptive
DE122009000007I2 (en)	1999-08-31	2011-07-21	Bayer Schering Pharma	Pharmaceutical combination of ethinyl estradiol and drospirenone as a contraceptive agent.
AU2001225413B2 (en)	2000-01-18	2005-06-23	Bayer Schering Pharma Aktiengesellschaft	Drospirenone for hormone replacement therapy
US20020132801A1 (en)	2001-01-11	2002-09-19	Schering Aktiengesellschaft	Drospirenone for hormone replacement therapy
US20040087563A1 (en)	2002-11-05	2004-05-06	Siegfried Mayerhofer	Hormone replacement therapy with cardiovascular protection using antialdosteronic progestins
US7786101B2 (en)	2002-11-05	2010-08-31	Bayer Schering Pharma Ag	Cardiovascular protection using anti-aldosteronic progestins
PL1748756T3 (en)	2004-03-10	2009-10-30	Bayer Schering Pharma Ag	Compositions comprising drospirenone molecularly dispersed
MY142989A (en)	2004-03-10	2011-02-14	Bayer Schering Pharma Ag	Stabilised supersaturated solids of lipophilic drugs
US20050220825A1 (en)	2004-03-10	2005-10-06	Adrian Funke	Molecular dispersions of drospirenone
MY151322A (en)	2004-04-30	2014-05-15	Bayer Ip Gmbh	Management of breakthrough bleeding in extended hormonal contraceptive regimens
JP5288796B2 (en)	2004-07-07	2013-09-11	ワイス・エルエルシー	Periodic progestin regimens and kits
EP1625849A1 (en)	2004-08-09	2006-02-15	Liconsa, Liberacion Controlada de Sustancias Activas, S.A.	Pharmaceutical composition comprising drospirenone and ethynylestradiol
ITMI20042338A1 (en)	2004-12-06	2005-03-06	Ind Chimica Srl	PROCESS FOR THE PREPARATION OF DROSPIRENONE
US20060293295A1 (en)	2005-05-13	2006-12-28	Kai Strothmann	Pharmaceutical composition comprising progestogens and/or estrogens and 5-methyl- (6S)-tetrahydrofolate
US8475838B2 (en)	2005-06-03	2013-07-02	Sandoz Ag	Rapidly-dissolving pharmaceutical composition for inhibiting ovulation
TW200727920A (en)	2005-06-21	2007-08-01	Organon Nv	New regimens for oral monophasic contraceptives
ES2311927T5 (en)	2005-07-21	2014-09-08	Bayer Pharma Aktiengesellschaft	Process for the production of 3-oxo-pregn-4-en-21.17-carbolactones by the metal-free oxidation of 17- (3-hydroxypropyl) -3,17-dihydroxyandrostanes
CN101489563A (en)	2006-07-06	2009-07-22	拜耳先灵医药股份有限公司	Pharmaceutical preparations for contraception and for preventing the risk of congenital malformations
EP2063870A2 (en) *	2006-09-16	2009-06-03	Bayer Schering Pharma Aktiengesellschaft	Oral modified release formulations
TW200930343A (en)	2007-09-21	2009-07-16	Organon Nv	Drug delivery system
WO2009100871A2 (en)	2008-02-13	2009-08-20	Bayer Schering Pharma Aktiengesellschaft	Drug delivery system with stabilising effect
WO2009138224A1 (en) *	2008-05-14	2009-11-19	Helm Ag	Pharmaceutical composition comprising drospirenone
DE102008037025C5 (en)	2008-08-08	2016-07-07	Jesalis Pharma Gmbh	Process for the preparation of crystalline drug microparticles or a solid state drug particle form
TW201008569A (en) *	2008-08-08	2010-03-01	Bayer Schering Pharma Ag	Progestin-containing drug delivery system
US10849857B2 (en)	2010-07-28	2020-12-01	Laboratorios Leon Farma Sa	Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
AR081670A1 (en) *	2010-06-29	2012-10-10	Leon Farma Sa Lab	PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE AND ANTI-ECONCEPTIVE KIT
US11351122B1 (en)	2010-07-28	2022-06-07	Laboratorios Leon Farma Sa	Synthetic progestogens and pharmaceutical compositions comprising the same
US9603860B2 (en)	2010-07-28	2017-03-28	Laboratorios Leon Farma Sa	Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same

2011
- 2011-06-27 AR ARP110102229A patent/AR081670A1/en not_active Application Discontinuation
- 2011-06-28 ES ES19209672T patent/ES2908657T3/en active Active
- 2011-06-28 EP EP11727985.1A patent/EP2588114B1/en active Active
- 2011-06-28 PL PL19209672T patent/PL3632448T3/en unknown
- 2011-06-28 PL PL11727985T patent/PL2588114T3/en unknown
- 2011-06-28 EP EP22150746.0A patent/EP4056186A1/en active Pending
- 2011-06-28 PE PE2012002518A patent/PE20130780A1/en active IP Right Grant
- 2011-06-28 CA CA3003062A patent/CA3003062C/en active Active
- 2011-06-28 DK DK19209672.5T patent/DK3632448T3/en active
- 2011-06-28 PT PT192096725T patent/PT3632448T/en unknown
- 2011-06-28 KR KR1020177019333A patent/KR102164693B1/en active IP Right Grant
- 2011-06-28 RS RS20200081A patent/RS59826B1/en unknown
- 2011-06-28 LT LTEP19209672.5T patent/LT3632448T/en unknown
- 2011-06-28 SM SM20220129T patent/SMT202200129T1/en unknown
- 2011-06-28 PE PE2016002187A patent/PE20161410A1/en unknown
- 2011-06-28 BR BR112012033391-7A patent/BR112012033391B1/en active IP Right Grant
- 2011-06-28 SI SI201132044T patent/SI3632448T1/en unknown
- 2011-06-28 CA CA2803721A patent/CA2803721C/en active Active
- 2011-06-28 RS RS20220179A patent/RS63027B1/en unknown
- 2011-06-28 KR KR1020137001350A patent/KR20130048227A/en active Search and Examination
- 2011-06-28 EP EP19209672.5A patent/EP3632448B1/en active Active
- 2011-06-28 KR KR1020217002806A patent/KR102539030B1/en active IP Right Grant
- 2011-06-28 WO PCT/EP2011/060795 patent/WO2012000981A1/en active Application Filing
- 2011-06-28 SI SI201131838T patent/SI2588114T1/en unknown
- 2011-06-28 CA CA3061421A patent/CA3061421C/en active Active
- 2011-06-28 HR HRP20220332TT patent/HRP20220332T1/en unknown
- 2011-06-28 JP JP2013517245A patent/JP5810159B2/en active Active
- 2011-06-28 NZ NZ605176A patent/NZ605176A/en unknown
- 2011-06-28 EA EA201291372A patent/EA028680B1/en unknown
- 2011-06-28 SM SM20200063T patent/SMT202000063T1/en unknown
- 2011-06-28 HU HUE19209672A patent/HUE058176T2/en unknown
- 2011-06-28 PH PH1/2012/502499A patent/PH12012502499A1/en unknown
2020
- 2020-02-03 CY CY20201100088T patent/CY1122544T1/en unknown
- 2020-06-11 FR FR20C1020C patent/FR20C1020I1/en active Active
- 2020-06-11 NO NO2020015C patent/NO2020015I1/en unknown
- 2020-06-11 HU HUS2000016C patent/HUS2000016I1/en unknown
2022
- 2022-03-10 CY CY20221100198T patent/CY1125061T1/en unknown
- 2022-04-11 US US17/717,550 patent/US11452695B2/en active Active
- 2022-05-10 HU HUS2200018C patent/HUS2200018I1/en unknown
- 2022-06-22 LT LTPA2022513C patent/LTPA2022513I1/lt unknown
- 2022-06-23 FR FR22C1031C patent/FR22C1031I2/en active Active
- 2022-06-29 US US17/853,623 patent/US11478487B1/en active Active
- 2022-06-30 US US17/855,432 patent/US11491113B1/en active Active
- 2022-07-01 US US17/856,605 patent/US11504334B2/en active Active
- 2022-07-11 NO NO2022030C patent/NO2022030I1/en unknown
- 2022-10-17 US US17/967,767 patent/US12090231B2/en active Active
2023
- 2023-08-04 US US18/365,877 patent/US11951213B2/en active Active
2024
- 2024-07-05 US US18/765,167 patent/US20240366512A1/en active Pending

Also Published As

Publication number	Publication date
BR112012033391A2 (en)	2016-11-22
PE20130780A1 (en)	2013-07-06
PL2588114T3 (en)	2020-05-18
BR112012033391B1 (en)	2020-02-27
SI2588114T1 (en)	2020-07-31
EP2588114A1 (en)	2013-05-08
LT3632448T (en)	2022-03-25
EP4056186A1 (en)	2022-09-14
SI3632448T1 (en)	2022-04-29
NO2020015I1 (en)	2020-06-11
PH12012502499A1 (en)	2013-03-25
EA028680B1 (en)	2017-12-29
RS63027B1 (en)	2022-04-29
PL3632448T3 (en)	2022-05-02
CA3003062A1 (en)	2012-01-05
CA3061421A1 (en)	2012-01-05
HUS2200018I1 (en)	2022-06-28
US11951213B2 (en)	2024-04-09
US20220339165A1 (en)	2022-10-27
HUS2000016I1 (en)	2020-07-28
SMT202200129T1 (en)	2022-05-12
NZ605176A (en)	2015-02-27
US20230046871A1 (en)	2023-02-16
WO2012000981A1 (en)	2012-01-05
AU2011273605B2 (en)	2016-05-26
ES2908657T3 (en)	2022-05-03
KR102539030B1 (en)	2023-05-31
KR20210013663A (en)	2021-02-04
DK3632448T3 (en)	2022-02-07
US20220241209A1 (en)	2022-08-04
US20240366512A1 (en)	2024-11-07
FR22C1031I2 (en)	2023-12-22
US11478487B1 (en)	2022-10-25
CA2803721A1 (en)	2012-01-05
US20220339106A1 (en)	2022-10-27
LTPA2022513I1 (en)	2022-07-11
US11491113B1 (en)	2022-11-08
KR102164693B1 (en)	2020-10-13
EP3632448A1 (en)	2020-04-08
BR112012033391A8 (en)	2018-04-17
PE20161410A1 (en)	2017-01-10
US11452695B2 (en)	2022-09-27
CY1125061T1 (en)	2023-06-09
HRP20220332T1 (en)	2022-05-13
CY1122544T1 (en)	2021-01-27
EP3632448B1 (en)	2022-01-12
US20220339107A1 (en)	2022-10-27
JP5810159B2 (en)	2015-11-11
CA2803721C (en)	2018-06-12
EA201291372A1 (en)	2013-06-28
NO2022030I1 (en)	2022-07-11
KR20130048227A (en)	2013-05-09
PT3632448T (en)	2022-03-07
US11504334B2 (en)	2022-11-22
CA3003062C (en)	2019-12-31
CA3061421C (en)	2021-06-01
KR20170085604A (en)	2017-07-24
US20230372248A1 (en)	2023-11-23
EP2588114B1 (en)	2019-12-25
AU2011273605A8 (en)	2016-07-28
US12090231B2 (en)	2024-09-17
RS59826B1 (en)	2020-02-28
FR20C1020I1 (en)	2020-08-07
SMT202000063T1 (en)	2020-03-13
JP2013529665A (en)	2013-07-22
AR081670A1 (en)	2012-10-10
AU2011273605A1 (en)	2013-01-17
HUE058176T2 (en)	2022-07-28

Publication	Publication Date	Title
FR22C1031I2 (en)	2023-12-22	PHARMACEUTICAL COMPOSITION COMPRISING DROSPIRENONE FOR USE AS A CONTRACEPTIVE
IL222738A0 (en)	2012-12-31	Pharmaceutical emulsion composition comprising progestogen
EP2646006A4 (en)	2014-06-25	PHARMACEUTICAL FORM
FR2959935B1 (en)	2013-02-08	ALCOHOL-RESISTANT ORAL PHARMACEUTICAL FORM
HK1190307A1 (en)	2014-07-04	Pharmaceutical cream compositions comprising oxymetazoline
HK1170686A1 (en)	2013-03-08	Pharmaceutical composition for emergency contraception
EP2627323A4 (en)	2014-03-12	ANTITUSSIVE COMPOSITIONS COMPRISING MÉMANTINE
FR2948568B1 (en)	2012-08-24	PHARMACEUTICAL FORMULATION
EP2548549A4 (en)	2015-08-05	COMPOSITION FOR EMULSION
EP2869838A4 (en)	2016-01-06	BIOFILM BACTERIAL MATRIX AS A PLATFORM FOR PROTEIN ADMINISTRATION
EP2460130A4 (en)	2013-03-27	Brokering system for location-based tasks
FR2997577B1 (en)	2015-12-04	BALANCING CONVERTER FOR BATTERIES COMPRISING DIAGNOSTIC MEANS
EP2642979A4 (en)	2014-09-17	PHARMACEUTICAL COMPOSITION
EP2723320A4 (en)	2014-12-03	LIQUID PHARMACEUTICAL COMPOSITION COMPRISING NITISINONE
EP2687549A4 (en)	2015-01-21	Lipophilic, highly branched polymer, and photopolymerizable composition containing the same
EP2540318A4 (en)	2014-04-23	SOLID RELEASE PREPARATION FOR ORAL USE
AU2013205605A1 (en)	2013-12-05	Paste-like bone cement
EP2540317A4 (en)	2014-04-16	SOLID RELEASE PREPARATION FOR ORAL USE
FR2955286B1 (en)	2017-03-24	MIXER FOR PLASTER PASTE
IL220709A (en)	2015-03-31	Sulfone compounds as 5-ht6 receptor ligands, process for their preparation, pharmaceutical compositions comprising them and use thereof
EP2548258A4 (en)	2013-08-07	IONIC LIQUIDS FOR BATTERIES
FR2945952B1 (en)	2013-10-04	ANTI-CK8 ANTIBODIES FOR USE AS A MEDICINAL PRODUCT.
FR2967577B1 (en)	2013-07-12	PHARMACEUTICAL COMPOSITION COMPRISING BICARBONATE SALT AND USE THEREOF AS A MEDICINAL PRODUCT
IT1398875B1 (en)	2013-03-21	COMPOSITIONS CONTENTS L. MUCOSAE FOR MEDICAL USE.
FR2956950B1 (en)	2012-04-13	DIVIDER FOR BAKERY PASTE